NEW YORK, Dec 7 – Luminex has signed a multi-year licensing agreement with Hitachi for the worldwide distribution rights to its LabMap kit of reagents and instrumentation, Luminex announced Thursday.

Under the agreement, MiraiBio, formerly Hitachi Genetic Systems, will offer the LabMap assay detection products to its customers along with its microarray, bioimaging, bioinformatics, and spectroscopy technologies.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.